Human Resource Management

HUMAN RESOURCE MANAGEMENT

Project SUBMITTED TO:

SIR .YASIR AFTAB FAROOQI

SUBMITTED BY:

Gulam Abbass 08011420-012

Group #2

MBA 2nd

UNIVERSITY OF GUJRAT

Human Resource Management

History

Novartis pharmaceutical is established in 1996.The history of Novartis traces back to three companies

Geigy Pharmaceutical Ciba pharmaceutical Sandoz pharmaceutical

Giegy whose origin goes back to the middle of the 18th century. CIBA founded around 1859and Sandoz established in 1886

In1970 CIBA and Giegy merged .the newly created CIBA-Geigy ltd and Sandoz continued to follow separate path for two and half decades

In1996 Sandoz and CIBA-Geigy joined to form Novartis pharmaceutical.

Head Office

Novartis International AGCH-4002 Basel

Switzerland

Tel: +41 61 324 11 11

Fax: +41 61 324 80 01

Head office in Pakistan

Novartis Pharma (Pakistan) LTD.15 West Wharf Road, Karachi 74000, Sindh, PakistanPhone: 9221-2313389 / 2316286 / 2313387 / 2313390Fax: 9221-2310241

Human Resource Management

Mission:

We want to discover, develop and successfully market innovative products to prevent and

cure diseases, to ease suffering and to enhance the quality of life.

We also want to provide a shareholder return that reflects outstanding performance and to

adequately reward those who invest ideas and work in our company.

Vision:

We want to discover, develop and successfully market innovative products to prevent and cure diseases, to ease suffering and to enhance the quality of life. We also want to provide a shareholder return that reflects outstanding performance and to adequately reward those who invest ideas and work in our company.

Sector Head

Farhan Baider Malik

15 West Wharf Road, Karachi 74000, Sindh, PakistanPhone: 9221-2313389 / 2316286 / 2313387 / 2313390Fax: 9221-2310241

Managers

Khalid Ashraf (National Sales Manager)

Moiz Haider (Brand Manager)

Zubair Ahmed (Training Manager)

Ali Imran (Human Resource Manager)

Moin Khan (Factory head)

Regional Sales Managers

Tuyyab Nazir   LahoreMujeeb Alam   MultanM Shakeel   KarachiArshad Iqbal   Islamabad

Human Resource Management

Zonal Sales Managers

Lahore

Muhammad Zeeshan AltafM. Sohail Aslam

Faisalabad

M. EjazQamer Shahzad Ali

Islamabad

Naveed BasheerIkram Ulah KhanM.Usman

Multan

Shahzad JamilGhazanfar Aziz GhauriQamar Zaman

Gujranwala

Abaid ur Rehman

Sukhar

Imtiaz SoomroAbdul Hameed

Karachi

Faizan Ur RehmanSyed Ather HussainAsif Ali Khan

Human Resource Management

Hyderabad

Jawaid JabbarSyed Shoaib HussainNaveed Farooque

Peshawar

Noorullah JanInayat Ullah Khan Afridi

Designation of contacted person

Ali Imran

ACCA, MBA (HRM)

(Human Resource Manager)

Phone: 9221-2313388 / 2316289

Fax: 9221-2310242

Human Resource Management

Company Competitors

Human Resource Management

PRODECTS CAC-1000 CAC 1000 Plus CAC 1000 Plus Pineapple VEG 20mg T DAY SPASMO CIBALGIN CALCIUM SAN. SYP.120ML TRIAMINIC SYP. 60ML TRIAMINIC SYP. 120ML TRIAMINIC-E SYP. 60ML TRIAMINIC-DM 60ML Triaminic Cold & Allergy Triaminic Cough Triaminic Chest Congestion Triaminic Cough, Cold & Fever TANDEGYL D TANDEGYL SYRUP NEO-INTESTOPAN 60 ml QALSAN MINT QALSAN MIX CALCIUM+VIT. C A50X10ML SANCOS TANDEGYL T-30 TANDEGYL-DS T-10 TANDEGYL INJ. A50X2ML LAMISIL CREAM LAMISIL SPRAY NEO-INTESTOPAN T 250 OPTALIDON T-200

Human Resource Management

SWOT ANALYSIS

Strengths

Market Leader Strong CNS image of Novartis Strong brand image-Heritage,

Valuation Strong rapport with KOLs High acceptance of carbamazepine as

an anti epileptic FDA approved Effective in multiple indications First line, first choice therapy

Weaknesses

Only one formulation is available No formulation for children Mostly under dosage is recommended Lack of resources to tap attractive

opportunities

Opportunities

High growth rate of the market More doctors particularly GPs are

diagnosing epilepsy High treatment gap Lot of potential in different indications

(PDN) New Molecules are high cost & with

low safety profile

Threats

High SoV of competition Increasingly high acceptance of

valproates Increased penetration of low cost

Generics in institutions Epival has many galenical forms Introduction of new molecules Compliance is low

Human Resource Management

WEAKNESSES

AND

THREATS

Weaknesses

Only one formulation is available No formulation for children Mostly under dosage is recommended Lack of resources to tap attractive

opportunities

Threats

Existing Threat: High Share of Voice of competition.

Increased penetration of low cost Generics in institutions

Rapid growth of below the line and direct to consumer advertising

Increasingly high acceptance of valproates

Epival has many galenical forms Potential Threat: Introduction of new

molecules Compliance is low Entry/exit into the Industry: Increase

in number of neuroscience competitive products. Consumers have been offered more and more choices.

Proposed Strategies

1. Formulation should be introduced for children and young adults.

2. Promotional Strategy to create awareness and increase mind share

3. Promote KOLs to increase the number of patients

4. Optimize the loyalty base of Tegral users

5. Switch Epival users to Tegral 6. Low dosage range extension should be

introduced7. In regions other than Karachi, Lahore

and Peshawar, distribution should be made more extensive to increase availability. More agents should be contacted

8. Management should strategize their aims to retain their sales force through benefit planning and incentives.

Human Resource Management

WEAKNESSES

AND

OPPURTUNITIES

Weaknesses

Only one formulation is available No formulation for children Mostly under dosage is recommended Lack of resources to tap attractive

opportunities

Opportunities

High growth rate of the market More doctors particularly GPs are

diagnosing epilepsy High treatment gap Lot of potential in different indications

(PDN) New Molecules are high cost & with

low safety profile

Proposed Strategies

Conduct seminars and workshops to train GPs about Epilepsy and the usage of Tegral.

Treatment gap should be reduced by awareness programs in rural areas.

Cost - plus pricing should be practiced for new molecules exposures and regulations for safety should be enhanced

Local firms desirous of export but lacking necessary export structure

Human Resource Management

STRENGTHS

AND

OPPURTUNITIES

Strengths

Market Leader Strong CNS image of Novartis Strong brand image-Heritage,

Valuation Strong rapport with KOLs High acceptance of carbamazepine as

an anti epileptic FDA approved Effective in multiple indications First line, first choice therapy

Opportunities

High growth rate of the market More doctors particularly GPs are

diagnosing epilepsy High treatment gap Lot of potential in different indications

(PDN) New Molecules are high cost & with

low safety profile

Proposed Strategies

Capitalize on strong CNS franchise – build further rapport with KOLs

Patient Evaluation Programs: For KOL Development

KEEP (Key Experts Evaluation Programs)- Painful Diabetic Neuropathies for 30 Physicians

BOC - 2 Programs for 30 Doctors each for PDN

Epilepsy Project

- CME Programs for Family Physicians (Epilepsy)

- Epilepsy Camps (28 camps organized so far)

Neuroscience Summit: Patient Evaluation Program for major Brands of Neuroscience, Total 35 Top KOLs from Neurology & Psychiatry

Human Resource Management

STRENGTHS

AND

THREATS

Strengths

Market Leader Strong CNS image of Novartis Strong brand image-Heritage,

Valuation Strong rapport with KOLs High acceptance of carbamazepine as

an anti epileptic FDA approved Effective in multiple indications First line, first choice therapy

Threats

Existing Threat: High Share of Voice of competition.

Increased penetration of low cost Generics in institutions

Rapid growth of below the line and direct to consumer advertising

Increasingly high acceptance of valproates

Epival has many galenical forms Potential Threat: Introduction of new

molecules Compliance is low Entry/exit into the Industry: Increase

in number of neuroscience competitive products. Consumers have been offered more and more choices.

Proposed Strategies

Build further rapport with KOLs Exploit on strong CNS franchise Patient Evaluation Programs should be

conducted for KOL Development Own distribution structure of Tegral,

measuring highest in clinical evaluation, effectiveness & safety

Summits of KOLs for top brands in neuroscience to increase share of voice

Focus to minimize substitution. More Focus on RMOS Better Awareness of Epilepsy Project Refine Advertisement media More sustained branding Powerful message delivery Monitor promotion in different

indications

Human Resource Management

Suggestions

They should provide proper training to employees so that they can easily understand the current technology.

They should organize some seminars.

HR should interact with labor as well as office staff.

HR should look after the problems of each employee and try to solve according his own experience.

They should provide some extra facilities such as bonuses, increments, visits to outside country so that they don’t think switch off.

HR should develop ethical practices. For this purpose they should set some rules and regulations.

Right person for the right job.

Looking for better ways of working after results in new ways of doing things.

HR manager must be prepared to train employees in the new process and help them train new level that may be associated with the “new. Improved” operations.